Learning Objectives:
- Explain the diagnostic strategy and management options for the asymptomatic individual with antiphospholipid antibodies
- Describe the assessment and management of the APS patient with VTE and ATE
- Define the role of complement in the patient with catastrophic APS and best treatment for the syndrome
- Describe the role of antiphospholipid antibodies in patients with COVID-19
Disclosures: None
CME Code: LASNOB
Location: Virtually on WebEx
Directions: If you are having trouble accessing WebEx, please contact Cassy Sims at cas206@duke.edu
Streaming: Via WebEx. Link: https://dukemed.webex.com/dukemed/j.php?MTID=m57511734eb4f3e4f0423f94de8a7eb34
Meeting Number/Access Code: 120-459-7417 (you will not need this if you use link above)
Call-in number: 1-650-479-3207
Add to calendar:
Session date:
10/19/2021 - 8:00am to 9:00am EDT
Room Number:
WebEx
Speaker Name:
Dr. Thomas Ortel